A Systematic Hierarchical Virtual Screening Model for RhlR Inhibitors Based on PCA, Pharmacophore, Docking, and Molecular Dynamics
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25148000 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Jiarui Du und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Jinan University, Guangzhou 511436, China. Hauptthemen laut MEDLINE: Molecular Docking Simulation, Molecular Dynamics Simulation, Pseudomonas aeruginosa, Principal Component Analysis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 144 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: by Natural Science Foundation of Guangdong Province, China Postdoctoral Science Foundation, Natural Science Foundation of Guangdong Province.
Abstract (Originalsprache)
RhlR plays a key role in the quorum sensing of Pseudomonas aeruginosa. The current structure–activity relationship (SAR) studies of RhlR inhibitors mainly focus on elucidating the functional groups. Based on a systematic review of previous research on RhlR inhibitors, this study aims to establish a systematic, hierarchical screening model for RhlR inhibitors. We initially established a database and utilized principal component analysis (PCA) to categorize the inhibitors into two classes. Based on the training set, pharmacophore models were established to elucidate the structural characteristics of ligands. Subsequently, molecular docking, molecular dynamics simulations, and the calculation of binding free energy and strain energy were performed to validate the crucial interactions between ligands and receptors. Then, the screening criteria for RhlR inhibitors were established hierarchically based on ligand structure characteristics, ligand–receptor interaction, and receptor affinity. Test sets were finally employed to validate the hierarchical virtual screening model by comparing it with the current SAR studies of RhlR inhibitors. The hierarchical screening model was confirmed to possess higher accuracy and a true positive rate, which holds promise for subsequent screening and the discovery of active RhlR inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Jinan University, Guangzhou 511436, China.
- State Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, Guangzhou 510632, China.
- Key Laboratory of Xinjiang Phytomedicine Resource and Utilization, Ministry of Education, School of Pharmacy, Shihezi University, Shihezi 832003, China.
ORCID-Profile: Jiahao Li, Dongdong Yang, Jun Xu
Förderung
- by Natural Science Foundation of Guangdong Province
- China Postdoctoral Science Foundation
- Natural Science Foundation of Guangdong Province
Zitieren
APA
Du, J., Li, J., Wen, J., Liu, J., Xiao, H., Zhang, A., Yang, D., Sun, P., Zhou, H., & Xu, J. (2024). A Systematic Hierarchical Virtual Screening Model for RhlR Inhibitors Based on PCA, Pharmacophore, Docking, and Molecular Dynamics. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25148000
Vancouver
Du J, Li J, Wen J, Liu J, Xiao H, Zhang A, et al. A Systematic Hierarchical Virtual Screening Model for RhlR Inhibitors Based on PCA, Pharmacophore, Docking, and Molecular Dynamics. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25148000
BibTeX
@article{Du2024,
author = {Du, Jiarui and Li, Jiahao and Wen, Juqi and Liu, Jun and Xiao, Haichuan and Zhang, Antian and Yang, Dongdong and Sun, Pinghua and Zhou, Haibo and Xu, Jun},
title = {A Systematic Hierarchical Virtual Screening Model for RhlR Inhibitors Based on PCA, Pharmacophore, Docking, and Molecular Dynamics},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25148000}
}
EUVIMED